Rchr
J-GLOBAL ID:201801018791688935   Update date: Feb. 02, 2023

Masayuki Shimojima

シモジマ マサユキ | Masayuki Shimojima
Papers (103):
  • Hideki Tani, Kengo Kawachi, Miyuki Kimura, Satoshi Taniguchi, Masayuki Shimojima, Shuetsu Fukushi, Manabu Igarashi, Shigeru Morikawa, Masayuki Saijo. Identification of the amino acid residue important for fusion of severe fever with thrombocytopenia syndrome virus glycoprotein. Virology. 2019. 535. 102-110
  • Hirosaki H, Maeda Y, Shimojima M, Maeda K, Iwata H, Takeyoshi M. Effects of Soluble Tumor Necrosis Factor (TNF) on Antibody-Dependent Cellular Cytotoxicity of Therapeutic anti-TNF-α Antibody. Immunological investigations. 2019. 48. 5. 441-450
  • Yuta Kanai, Takahiro Kawagishi, Yusuke Sakai, Ryotaro Nouda, Masayuki Shimojima, Masayuki Saijo, Yoshiharu Matsuura, Takeshi Kobayashi. Cell-cell fusion induced by reovirus FAST proteins enhances replication and pathogenicity of non-enveloped dsRNA viruses. PLoS pathogens. 2019. 15. 4. e1007675
  • Motohiko Ogawa, Yoshitaka Shirasago, Shuji Ando, Masayuki Shimojima, Masayuki Saijo, Masayoshi Fukasawa. Corrigendum to caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro [J Infect Chemother 24 (8) (2018) 597-601]. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019. 25. 2. 161-161
  • Masaaki Satoh, Shintaro Akashi, Motohiko Ogawa, Takatoshi Wakeyama, Hiroshi Ogawa, Aiko Fukuma, Satoshi Taniguchi, Hideki Tani, Takeshi Kurosu, Shuetsu Fukushi, et al. Corrigendum to "Retrospective survey of severe fever with thrombocytopenia syndrome in patients with suspected rickettsiosis in Japan" [J Infect Chemother 23 (1) (2018) 45-50]. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019. 25. 2. 162-162
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page